# 专科虚拟病人 vs OSVE线下版

The clearest difference is update cadence: 专科虚拟病人 at monthly against OSVE线下版's every 3 months. OSVE线下版's advantage is iOS requirement (11.0 vs 13.0). On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

专科虚拟病人 ships an update monthly, OSVE线下版 every 3 months. The most recent releases landed on October 17, 2026 and October 14, 2026 respectively.

## The numbers

| Metric | 专科虚拟病人 | OSVE线下版 |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[5.0 (1 ratings)](https://appshunter.io/ios/app/id6467720542/reviews)** | — |
| Number of ratings | **1** | — |
| Positive reviews | 100.0% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Monthly** | Every 3 months |
| Size | 271 MB | 21 MB |
| Requires iOS | 13.0 | **11.0** |
| Devices | **iPhone, iPad, iPod, Mac** | iPhone, iPad, iPod |
| Age rating | 17+ | 12+ |
| Developer | [上海华颐医疗科技有限公司](https://appshunter.io/developer/1446549601) | [Tellyes Scientific Co., Ltd.](https://appshunter.io/developer/1207633554) |

## What reviewers say

### 专科虚拟病人

[App page](https://appshunter.io/ios/app/id6467720542)

**Features:** Vision Pro support

**In-app purchases:** none


### OSVE线下版

[App page](https://appshunter.io/ios/app/osve/id6742483735)

**Features:** macOS Compatibility

**In-app purchases:** none


## Frequently asked questions

### Is 专科虚拟病人 free?

专科虚拟病人 is free to download, with no in-app purchases.

### Is OSVE线下版 free?

OSVE线下版 is free to download, with no in-app purchases.

### Do 专科虚拟病人 or OSVE线下版 have ads?

Neither 专科虚拟病人 nor OSVE线下版 shows ads.

### Which is updated more often, 专科虚拟病人 or OSVE线下版?

专科虚拟病人 ships an update monthly, and OSVE线下版 every 3 months. Most recently, 专科虚拟病人 was updated on October 17, 2026 and OSVE线下版 on October 14, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*